Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma
Enrica Marchi, Alexander G. Raufi, Owen A. O’Connor
Hematology/Oncology Clinics of North America (2017) Vol. 31, Iss. 2, pp. 359-375
Closed Access | Times Cited: 12

Showing 12 citing articles:

Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma
Ping Zhang, Mingzhi Zhang
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 68
Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS)
Adetokunbo Oluwasanjo, Saritha Kartan, W. Thomas Johnson, et al.
Cancer treatment and research (2018), pp. 83-98
Closed Access | Times Cited: 33
Microbial Secondary Metabolites Used Against Diabetes and Cancer—A Critical Appraisal
Sheetal Gupta, Wazen Longkumer, Andrew G. Stephen
(2025), pp. 171-186
Closed Access
Emerging antibody-drug conjugates for treating lymphoid malignancies
Anna Wolska, Paweł Robak, Piotr Smolewski, et al.
Expert Opinion on Emerging Drugs (2017) Vol. 22, Iss. 3, pp. 259-273
Closed Access | Times Cited: 21
Strategy for Assessing New Drug Value in Orphan Diseases: An International Case Match Control Analysis of the PROPEL Study
Owen A. O’Connor, Enrica Marchi, Weining Volinn, et al.
JNCI Cancer Spectrum (2018) Vol. 2, Iss. 4
Open Access | Times Cited: 20
Lymph node fine‐needle cytology in the era of personalised medicine. Is there a role?
Immacolata Cozzolino, Valentina Giudice, Chiara Mignogna, et al.
Cytopathology (2019) Vol. 30, Iss. 4, pp. 348-362
Closed Access | Times Cited: 15
T-cell therapies for T-cell lymphoma
Keri Toner, Catherine M. Bollard, Hema Dave
Cytotherapy (2019) Vol. 21, Iss. 9, pp. 935-942
Closed Access | Times Cited: 14
<p>TLR4 expression correlated with PD-L1 expression indicates a poor prognosis in patients with peripheral T-cell lymphomas</p>
Shu Zhao, Mengqi Sun, Hongxue Meng, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 4743-4756
Open Access | Times Cited: 13
The anti-tumor activity of pralatrexate (PDX) correlates with the expression of RFC and DHFR mRNA in preclinical models of multiple myeloma
Cristina Kinahan, Michael Mangone, Luigi Scotto, et al.
Oncotarget (2020) Vol. 11, Iss. 18, pp. 1576-1589
Open Access | Times Cited: 8
Diagnosis Dilemma of Angioimmunoblastic T-Cell Lymphoma in Tuberculosis Endemic Region
Sokhna Aïssatou Touré, Moussa Seck, Alioune Diallo, et al.
Case Reports in Hematology (2020) Vol. 2020, pp. 1-4
Open Access | Times Cited: 5
Autologous stem cell transplant for refractory and relapsed peripheral T-cell lymphoma: a retrospective study in China
Chen Zhang, Jie Lv, Jili Deng, et al.
Journal of Cancer (2023) Vol. 15, Iss. 2, pp. 539-544
Open Access | Times Cited: 1

Cristina Kinahan, Michael Mangone, Luigi Scotto, et al.
Oncotarget (2020) Vol. 11, Iss. 18
Open Access | Times Cited: 2
Page 1

Scroll to top